Stockscreener 앱 받기
272.54
2.09%
5.58
시간 외 거래:
272.54
전일 마감가:
$266.96
열려 있는:
$268.96
하루 거래량:
669.63K
Relative Volume:
0.97
시가총액:
$19.61B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
40.83
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
-3.28%
1개월 성능:
-1.76%
6개월 성능:
+21.66%
1년 성능:
-14.35%
1일 변동 폭
$267.90
$274.56
1주일 범위
$263.38
$283.52
52주 변동 폭
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
272.54 | 19.21B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
547.36 | 197.07B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.43 | 56.63B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.76 | 39.40B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.39 | 36.71B | 5.26B | 1.44B | 1.76B | 9.7713 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now - Nasdaq
West Pharmaceutical Services, Inc. Declares Regular Quarterly Dividend on Common Stock, Payable on February 4, 2026 - marketscreener.com
West Pharmaceutical Services Keeps Quarterly Dividend at $0.22 a Share, Payable Feb. 4 to Shareholders of Record on Jan. 28 - marketscreener.com
West Pharmaceutical Services declares quarterly dividend of $0.22 By Investing.com - Investing.com Australia
West Pharmaceutical Services declares quarterly dividend of $0.22 - Investing.com India
West Declares Quarterly Dividend - PR Newswire
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
North Growth Management Ltd. Acquires 4,000 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Invesco Ltd. Boosts Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Purchased by Amundi - MarketBeat
Arrowstreet Capital Limited Partnership Has $28.23 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
XTX Topco Ltd Sells 8,822 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Stake Cut by Baird Financial Group Inc. - MarketBeat
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST - The National Law Review
West Pharmaceutical Services (NYSE:WST) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
How West Pharmaceutical Services Inc. stock performs in high volatility marketsEarnings Trend Report & High Conviction Investment Ideas - Newser
M&T Bank Corp Reduces Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
The Bull Case For West Pharmaceutical Services (WST) Could Change Following Margin Squeeze And Slower Revenue Growth - Yahoo Finance
$1.22 Bn Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035: Growth Driven by Shift From Broad-Spectrum Treatments to Personalized Therapeutic Development - GlobeNewswire Inc.
West Pharmaceutical Services named Medtech Company of the Year at Irish Medtech Awards - businessplus.ie
Epoch Investment Partners Inc. Raises Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
Fisher Asset Management LLC Has $5.33 Million Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Will West Pharmaceutical Services Inc. stock profit from AI boom2025 Trade Ideas & Low Drawdown Trading Strategies - Newser
What makes West Pharmaceutical Services Inc. stock appealing to growth investorsJuly 2025 Pullbacks & Pattern Based Trade Signal System - Newser
West Pharmaceutical Services (WST) Rebounded in Q3 - Finviz
Quantbot Technologies LP Grows Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Earnings Notes - Trefis
Why global investors buy West Pharmaceutical Services Inc. (WPS) stockWeekly Investment Report & Verified Swing Trading Watchlist - Newser
3 Reasons WST is Risky and 1 Stock to Buy Instead - Markets Financial Content
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Norges Bank Takes $200.81 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Schroder Investment Management Group Purchases 7,350 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Why millennials buy West Pharmaceutical Services Inc. (WPS) stockPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - Newser
Pharmaceutical Cartridges Industry Forecast Reveals - openPR.com
Will West Pharmaceutical Services Inc. stock keep raising dividendsProduct Launch & Free Reliable Trade Execution Plans - Newser
Transcript : West Pharmaceutical Services, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 02 - marketscreener.com
Edgestream Partners L.P. Purchases New Shares in West Pharmaceutical Services, Inc. $WST - MarketBeat
Morgan Stanley Initiates West Pharmaceutical Services at Equalweight With $285 Price Target - marketscreener.com
JPMorgan Chase & Co. Sells 435,132 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
How West Pharmaceutical Services Inc. (WPS) stock reacts to new regulationsWeekly Profit Summary & Real-Time Buy Signal Alerts - Newser
Hsbc Holdings PLC Sells 5,060 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Published on: 2025-12-02 02:46:24 - Newser
Morgan Stanley Initiates Coverage of West Pharmaceutical Services (WST) with Equal-Weight Recommendation - MSN
How strong dollar benefits West Pharmaceutical Services Inc. stockJuly 2025 Review & High Conviction Investment Ideas - Newser
West Pharmaceutical Services (WST): Evaluating Valuation After Recent Momentum Shift - Sahm
West Pharmaceutical Services earns excellence award for syringe innovation - Traders Union
West Pharmaceutical: Back To Growth (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services Wins Product Launch Award for Its West Synchrony S1 Prefillable Syringe System - Pharmaceutical Technology
WST Investors Have Opportunity to Lead West Pharmaceutical Servic - The National Law Review
Russell Investments Group Ltd. Raises Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Charles Schwab Investment Management Inc. Acquires 10,527 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
0.43%
자본화:
|
볼륨(24시간):